EPRX · Insider trading · 13F holders · Congress trades
Eupraxia Pharmaceuticals Inc (EPRX)
Who is buying and selling EPRX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 12
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
EPRX at a glance
- No open-market insider purchases or sales of EPRX were filed in the last 90 days.
- 12 13F filers hold EPRX among their 50 largest positions, worth $56.2M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (2.1%), Great Point Partners LLC (1.9%) and Velan Capital Investment Management LP (1.4%). In their latest 13Fs, 1 manager opened a new position and 1 added to one.
- No member of Congress has disclosed a trade in EPRX.
EPRX insider trading
No open-market insider purchases or sales of EPRX were filed in the last 90 days.
Who owns EPRX? Hedge funds and superinvestors
12 13F filers hold EPRX among their 50 largest positions, worth $56.2M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (2.1%), Great Point Partners LLC (1.9%) and Velan Capital Investment Management LP (1.4%). In their latest 13Fs, 1 manager opened a new position and 1 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLCHedge fund | 0.5% | $10.9M | 1,650,000 | +3.8% shares | Q2 2026 |
| Vivo Capital, LLCHedge fund | 0.8% | $8.9M | 1,350,000 | +0.0% shares | Q2 2026 |
| PFM Health Sciences, LPHedge fund | 0.7% | $8.0M | 1,210,661 | — | Q2 2026 |
| Great Point Partners LLCHedge fund | 1.9% | $7.9M | 1,200,000 | +0.0% shares | Q2 2026 |
| Ikarian Capital, LLCHedge fund | 0.9% | $5.4M | 809,741 | -33.3% shares | Q2 2026 |
| Redmile Group, LLCHedge fund | 0.3% | $4.0M | 611,400 | -12.7% shares | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 0.7% | $4.0M | 610,785 | +40.9% shares | Q2 2026 |
| Velan Capital Investment Management LPHedge fund | 1.4% | $2.3M | 352,000 | +0.0% shares | Q2 2026 |
| Aisling Capital Management LPHedge fund | 0.5% | $2.1M | 325,000 | +0.0% shares | Q2 2026 |
| Ally Bridge Group (NY) LLCHedge fund | 2.1% | $1.7M | 252,175 | -61.8% shares | Q2 2026 |
| Delaney Capital Management Ltd.Hedge fund | 0.1% | $768K | 117,200 | -1.8% shares | Q2 2026 |
| Lynx1 Capital Management LPHedge fund | 0.0% | $66K | 10,000 | New | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 12). Screen EPRX in the grand portfolio →
EPRX stock trades by members of Congress
No member of Congress has disclosed a trade in EPRX.
EPRX questions and answers
Are insiders buying EPRX stock?
No open-market insider purchases or sales of EPRX were filed in the last 90 days.
Which hedge funds own EPRX?
12 13F filers hold EPRX among their 50 largest positions, worth $56.2M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (2.1%), Great Point Partners LLC (1.9%) and Velan Capital Investment Management LP (1.4%). In their latest 13Fs, 1 manager opened a new position and 1 added to one.
Has Congress traded EPRX?
No member of Congress has disclosed a trade in EPRX.
Who is the largest holder of EPRX?
Among 13F filers, Affinity Asset Advisors, LLC reports the largest EPRX position, $10.9M (1,650,000 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Ally Bridge Group (NY) LLC's: 2.1% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.